Cargando…
291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781705/ http://dx.doi.org/10.1093/ofid/ofu052.157 |
| _version_ | 1783295018691198976 |
|---|---|
| author | Chaftari, Anne-Marie Hachem, Ray Jordan, Mary Garoge, Kumait Al Hamal, Zainab El Zakhem, Aline Viola, George M. Granwwehr, Bruno Gagel, Andrew Jiang, Ying Al Shuaibi, Munirah Raad, Issam |
| author_facet | Chaftari, Anne-Marie Hachem, Ray Jordan, Mary Garoge, Kumait Al Hamal, Zainab El Zakhem, Aline Viola, George M. Granwwehr, Bruno Gagel, Andrew Jiang, Ying Al Shuaibi, Munirah Raad, Issam |
| author_sort | Chaftari, Anne-Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5781705 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57817052018-03-01 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients Chaftari, Anne-Marie Hachem, Ray Jordan, Mary Garoge, Kumait Al Hamal, Zainab El Zakhem, Aline Viola, George M. Granwwehr, Bruno Gagel, Andrew Jiang, Ying Al Shuaibi, Munirah Raad, Issam Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781705/ http://dx.doi.org/10.1093/ofid/ofu052.157 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Chaftari, Anne-Marie Hachem, Ray Jordan, Mary Garoge, Kumait Al Hamal, Zainab El Zakhem, Aline Viola, George M. Granwwehr, Bruno Gagel, Andrew Jiang, Ying Al Shuaibi, Munirah Raad, Issam 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| title | 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| title_full | 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| title_fullStr | 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| title_full_unstemmed | 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| title_short | 291 Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| title_sort | 291 efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781705/ http://dx.doi.org/10.1093/ofid/ofu052.157 |
| work_keys_str_mv | AT chaftariannemarie 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT hachemray 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT jordanmary 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT garogekumait 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT alhamalzainab 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT elzakhemaline 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT violageorgem 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT granwwehrbruno 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT gagelandrew 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT jiangying 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT alshuaibimunirah 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients AT raadissam 291efficacyandsafetyoftelavancininthetreatmentoframpositivebloodstreaminfectionsincancerpatients |